Nasal Saline Irrigation Guidelines

Introduction to Nasal Saline Irrigation

• The optimal frequency for nasal saline rinses is twice daily, and while saline irrigation is generally safe, excessive use beyond this recommendation can potentially strip the nasal mucosa of protective elements and natural moisture 1
• Twice daily irrigation is the most commonly recommended frequency in clinical studies and guidelines, with the American Academy of Otolaryngology-Head and Neck Surgery recommending isotonic saline for routine use to help thin mucus and improve mucociliary clearance 1, 2

Post-Operative Care

• Patients may benefit from more frequent irrigation (3-4 times daily) in the immediate post-operative period to clear debris and crusting, and should gradually reduce to twice daily maintenance after healing (typically 2-4 weeks) 1

Technique and Device Management

• Use proper technique: tilt head forward over sink, breathe through mouth during irrigation, and adjust water temperature to lukewarm (body temperature) for comfort and effectiveness 1
• Clean irrigation devices thoroughly after each use to prevent bacterial contamination, and allow adequate drainage after irrigation to prevent fluid retention in sinuses 1

Recommendations for Specific Populations

• Twice daily is still the optimal frequency for children who can tolerate the procedure, although lower volumes and gentler pressure are recommended, and infants under 2 months of age can experience respiratory distress due to nasal congestion, making saline nasal irrigation a safe and effective first-line treatment 1, 3
• Saline nasal irrigation followed by gentle suctioning is recommended for infants, with improvements in peaceful sleep, quality of feeding, and respiration, and deep suctioning should be avoided as it may cause nasal trauma, mucosal irritation, and potentially longer duration of symptoms 3

Risks and Adverse Effects

• Excessive use of nasal saline irrigation may lead to depletion of protective nasal mucus, disruption of normal nasal flora, nasal dryness and irritation, and increased risk of epistaxis (nosebleeds) from mechanical trauma to nasal mucosa 1
• Prolonged decongestant use should be avoided due to the risk of rhinitis medicamentosa, and decongestant sprays should not be used for more than 5 days without intranasal corticosteroids, to avoid rebound congestion 2, 1

Treatment of Nasal Congestion

• Intranasal corticosteroids are the most effective monotherapy for nasal congestion and should be the first-line treatment for persistent nasal congestion, according to the American Academy of Allergy, Asthma, and Immunology, with a rapid onset of action (3-12 hours) and full effect in 1-2 weeks, and minimal systemic side effects when used at recommended doses 4
• Intranasal antihistamines have a rapid onset of action (15-30 minutes) and are more effective than oral antihistamines for nasal congestion, but may have side effects such as bitter taste and potential somnolence, as reported by the American Academy of Allergy, Asthma, and Immunology 4
• The American Academy of Allergy, Asthma, and Immunology recommends a step-wise approach to nasal congestion treatment, starting with daily intranasal corticosteroid as primary therapy, adding saline irrigation before corticosteroid application, and considering short-term use of decongestant spray for breakthrough congestion 4

Surgical Treatment of Rhinosinusitis

• Functional endoscopic sinus surgery (FESS) is the standard surgical method for treating rhinosinusitis associated with nasal polyposis, with kortikosteroidni implantati significantly reducing nasal obstruction and the need for reoperation (odds ratio 0.34), as recommended by the European Position Paper on Rhinosinusitis and Nasal Polyps, with a strength of evidence level of high 1, 4
• The following table summarizes the recurrence rates of nasal polyps after surgery:

• Regular use of intranasal corticosteroids can prevent polyp recurrence after surgery and provide longer time to relapse compared to placebo, and failure to prescribe maintenance intranasal corticosteroids significantly increases recurrence risk, as recommended by the European Position Paper on Rhinosinusitis and Nasal Polyps, with a strength of evidence level of high 1

Special Considerations

• Aspirin-exacerbated respiratory disease (AERD) is present in 13% of patients with nasal polyposis, with poorer outcomes after FESS, and desensitization to aspirin followed by long-term daily aspirin therapy may be considered, with long-term studies suggesting that aspirin maintenance therapy can reduce nasal symptoms and need for systemic corticosteroids, as recommended by the European Position Paper on Rhinosinusitis and Nasal Polyps, with a strength of evidence level of moderate 4
• Systemic corticosteroids are recommended for severe cases, with a typical dose of prednizolon 25-60 mg for 7-20 days, significantly improving sense of smell and nasal airflow, and should be followed by intranasal corticosteroids to maintain the effect, as recommended by the European Position Paper on Rhinosinusitis and Nasal Polyps, with a strength of evidence level of moderate 1, 4